The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis

Currently, immune checkpoint blockade against members of the B7/CD28 family is being used as a new molecular-targeted therapy, in patients with unresectable advanced or recurrent gastric cancer. Although human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) is a novel mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimonosono, Masataka, Arigami, Takaaki, Yanagita, Shigehiro, Matsushita, Daisuke, Uchikado, Yasuto, Kijima, Yuko, Kurahara, Hiroshi, Kita, Yoshiaki, Mori, Shinichiro, Sasaki, Ken, Omoto, Itaru, Maemura, Kosei, Uenosono, Yoshikazu, Ishigami, Sumiya, Natsugoe, Shoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955131/
https://www.ncbi.nlm.nih.gov/pubmed/29774123
http://dx.doi.org/10.18632/oncotarget.25179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955131/
https://www.ncbi.nlm.nih.gov/pubmed/29774123
http://dx.doi.org/10.18632/oncotarget.25179

Ejemplares similares